Shelton A A, Lehman R E, Schrock T R, Welton M L
Department of Surgery, University of California, San Francisco, USA.
Arch Surg. 1996 Aug;131(8):806-10; discussion 810-1. doi: 10.1001/archsurg.1996.01430200016003.
To review patient characteristics, surgical indications, operative procedures, and survival of patients with ulcerative colitis who develop colorectal cancer.
Retrospective medical record review.
Tertiary referral center.
Of 493 patients who underwent surgery for ulcerative colitis between 1978 and 1994, 25 patients had colorectal cancer.
All patients underwent surgical exploration and either a biopsy, segmental resection, total abdominal colectomy, or restorative proctocolectomy was performed.
Duration of postoperative disease-free survival.
The average duration of illness prior to surgery was 18.5 years (range, 0.25-40 years). Surgical indications were intractability for 3 patients (12%); dysplasia as revealed by colonoscopic biopsy for 8 patients (32%); and preoperatively diagnosed cancer for 14 patients (56%). Three patients (12%) underwent exploratory laparotomy, 3 (12%) underwent right hemicolectomy, 5 (20%) underwent total proctocolectomy with ileostomy, 3 (12%) underwent total proctocolectomy with continent ileostomy, and 12 (48%) underwent restorative proctocolectomy. Pathological stage was carcinoma in situ for 3 patients (12%), stage I for 7 patients (28%), stage II for 4 patients (16%), stage III for 6 patients (25%), and stage IV for 5 patients (20%). Five-year survival was 100% (3/3) for patients with carcinoma in situ, 100% (4/4) for those with stage I disease, 50% (2/4) for those with stage II, 25% (1/4) for those with stage III, and 0% (0/5) for those with stage IV. Of the 12 patients treated with a restorative proctocolectomy, 6 are 5-year survivors, and 4 are alive at 24, 36, 38, and 48 months.
Twelve percent of the patients in this series had no preoperative evidence of colorectal malignant neoplasms but had invasive cancer in the resected specimen. Therefore, duration of disease alone may be an indication for surgery. A restorative proctocolectomy is a satisfactory procedure in selected patients with malignant neoplasms.
回顾溃疡性结肠炎并发结直肠癌患者的特征、手术指征、手术方式及生存率。
回顾性病历研究。
三级转诊中心。
1978年至1994年间接受溃疡性结肠炎手术的493例患者中,25例患有结直肠癌。
所有患者均接受手术探查,并进行活检、节段性切除、全腹结肠切除术或保留直肠的结肠切除术。
术后无病生存期。
手术前平均病程为18.5年(范围0.25 - 40年)。手术指征为:3例(12%)病情顽固;8例(32%)经结肠镜活检发现发育异常;14例(56%)术前诊断为癌症。3例(12%)接受了剖腹探查术,3例(12%)接受了右半结肠切除术,5例(20%)接受了全直肠结肠切除术并造瘘,3例(12%)接受了全直肠结肠切除术并建立可控性造瘘,12例(48%)接受了保留直肠的结肠切除术。病理分期为原位癌3例(12%),I期7例(28%),II期4例(16%),III期6例(25%),IV期5例(20%)。原位癌患者5年生存率为100%(3/3),I期患者为100%(4/4),II期患者为50%(2/4),III期患者为25%(1/4),IV期患者为0%(0/5)。接受保留直肠结肠切除术的12例患者中,6例存活5年,4例分别在24、36、38和48个月时仍存活。
本系列中12%的患者术前无结直肠恶性肿瘤证据,但切除标本中发现浸润性癌。因此,仅病程长短可能是手术指征。对于部分患有恶性肿瘤的患者,保留直肠的结肠切除术是一种令人满意的手术方式。